Health In Tech (NASDAQ:HIT – Get Free Report) and National Research (NASDAQ:NRC – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership.
Risk and Volatility
Health In Tech has a beta of 3.02, indicating that its stock price is 202% more volatile than the S&P 500. Comparatively, National Research has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500.
Insider and Institutional Ownership
47.3% of National Research shares are held by institutional investors. 71.0% of Health In Tech shares are held by company insiders. Comparatively, 9.2% of National Research shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Health In Tech and National Research”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Health In Tech | $32.83 million | 0.66 | -$12.45 million | ($0.19) | -1.74 |
| National Research | $137.39 million | 4.07 | $11.60 million | $0.28 | 94.04 |
National Research has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current recommendations for Health In Tech and National Research, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Health In Tech | 1 | 0 | 1 | 1 | 2.67 |
| National Research | 0 | 2 | 1 | 0 | 2.33 |
Health In Tech currently has a consensus price target of $3.50, indicating a potential upside of 961.25%. National Research has a consensus price target of $27.00, indicating a potential upside of 2.54%. Given Health In Tech’s stronger consensus rating and higher possible upside, equities analysts plainly believe Health In Tech is more favorable than National Research.
Profitability
This table compares Health In Tech and National Research’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Health In Tech | N/A | N/A | N/A |
| National Research | 4.48% | 313.25% | 14.32% |
Summary
National Research beats Health In Tech on 9 of the 14 factors compared between the two stocks.
About Health In Tech
Health In Tech, Inc. is a U.S.-based insurance technology company that provides a platform for businesses and insurance professionals involved in employee health benefits. Its technology connects employers and brokers with insurance carriers, third-party administrators and other service providers. The company focuses on self-funded and level-funded group health plans. Its platform supports processes such as plan quoting, underwriting and enrollment, with the aim of helping employers and brokers compare and arrange coverage.
About National Research
National Research Corporation, which operates as NRC Health, provides experience-management and consumer-insights services to organizations in the health care industry. Its research and technology help clients understand how patients, health care consumers and employees perceive their services. The company’s offerings include patient and consumer surveys, employee-engagement research, reputation measurement, analytics and related advisory services. Hospitals, health systems and other health care organizations use these tools to identify opportunities to improve service and strengthen relationships with the communities they serve.
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.
